![Důležité termíny](https://cdn.muni.cz/media/3633704/image_2.jpg?mode=crop¢er=0.5,0.5&rnd=133572412150000000&heightratio=0.5&width=278)
Informace o publikaci
Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity
Autoři | |
---|---|
Rok publikování | 2020 |
Druh | Článek v odborném periodiku |
Časopis / Zdroj | CASE REPORTS IN ONCOLOGY |
Fakulta / Pracoviště MU | |
Citace | |
www | https://www.karger.com/Article/Pdf/506829 |
Doi | http://dx.doi.org/10.1159/000506829 |
Klíčová slova | Fluciclovine; Incidental uptake; Neuroendocrine tumour |
Popis | 18F-fluciclovine is a PET radiopharmaceutical used for the detection of recurrent prostate cancer in adult men after primary curative treatment with suspicion of recurrence based on elevated prostate-specific antigen level. Several incidental uptakes of 18F-fluciclovine in other tumour types have been described in the literature so far - in breast cancer, hepatocellular carcinoma, and malignant melanoma. Our case report presents a patient with oncological duplicity (prostate gland carcinoma and newly diagnosed neuroendocrine tumour) and with accumulation of fluciclovine in pathologically proved neuroendocrine tumour, later imagined also by octreotide SPECT/CT. To our knowledge, this is the first case of fluciclovine accumulated in a neuroendocrine tumour described in the literature. |